← All trials
NCT05416151
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 24, 2022
- Primary completion
- Oct 1, 2023
- Completion date
- Oct 1, 2023
- First posted
- Jun 13, 2022
- Last posted
- Jun 13, 2022
- Enrollment
- 580
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Danone ResearchLead sponsor
- Danone ResearchStudy chair
- EURAXI PharmaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.